4DMedicalFDMDF -6.67%46 EV-to-EBIT is -15.12 as of Jul. 09, 2026. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 465 Medical Devices & Instruments companies, 4DMedical ranks worse than 215053.55% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
4DMedical's Enterprise Value for the quarter that ended in Dec. 2025 was $1,224.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4DMedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-109.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical EV-to-EBIT Related Terms
4DMedical EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for 4DMedical's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 4DMedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where 4DMedical's EV-to-EBIT falls into.
4DMedical's current Enterprise Value is $1,657.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4DMedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-109.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (FDMDF) has a EV-to-EBIT of -15.12 as of Jul. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #999999 out of 465 companies in the Medical Devices & Instruments industry.
Is 4DMedical's EV-to-EBIT too high?
4DMedical's current EV-to-EBIT is -15.12. Based on the distribution chart, 4DMedical ranks #999999 out of 465 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #999999 out of 465 companies for EV-to-EBIT. This places 4DMedical in the lower half of its industry. The industry median EV-to-EBIT is 18.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.57, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current EV-to-EBIT is -15.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current EV-to-EBIT is -15.12. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For 4DMedical (FDMDF), the current EV-to-EBIT is -15.12 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (FDMDF) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for FDMDF:
EV-to-EBIT: -15.12
GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score
Get the complete analysis for FDMDF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FDMDF has been successfully added to your 
